新興鑄管(000778.SZ):2023年全年實現鑄管銷量逆勢增長3.8%,產能利用率遠高於行業平均水平
格隆匯4月15日丨新興鑄管(000778.SZ)在投資者互動平台表示,2023年,鋼鐵行業步入下行週期,市場供需結構矛盾凸顯、強預期與弱現實交織,鋼材價格震盪下行,原燃料價格持續高位。為有效應對行業週期性變化,公司因時因勢調整經營策略,強化聯動協同,優化資源配置,推動經營質量和效益的提升。全年實現鑄管銷量逆勢增長3.8%,產能利用率遠高於行業平均水平;鋼材產銷率100%,產品結構持續優化;管鑄件產量同比增長8%、鋼格板銷量同比增長25%,均創歷史最好水平;噸鋼獲利能力保持行業第一陣營。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.